Mini report 14. DEC 2015 Cost-benefit analyse af fremtidige vaccineberedskaber over for kopper i Danmark Imvanex® versus den nuværende danske koppevaccine Authors: Betina Højgaard Staged photo: Lars Degnbol/VIVE Page created Monday, November 21, 2022 Page updated Saturday, April 25, 2026 Download Download Authors Betina Højgaard About this publication Publisher KORA